Mylan CEO defends 500% price spike in life-saving drug EpiPen

Sep 21, 2016

Mylan CEO defends 500% price spike in life-saving drug EpiPen

The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens and is signaling the company has no plans to lower prices despite a public outcry. “Price and access exist in a balance, and we believe we have struck that balance,” Heather ...